| Angiogenesis in cancer and other diseases P Carmeliet, RK Jain nature 407 (6801), 249-257, 2000 | 11916 | 2000 |
| Molecular mechanisms and clinical applications of angiogenesis P Carmeliet, RK Jain Nature 473 (7347), 298-307, 2011 | 6080 | 2011 |
| Mechanisms of angiogenesis and arteriogenesis P Carmeliet Nature medicine 6 (4), 389-395, 2000 | 5990 | 2000 |
| Angiogenesis in health and disease P Carmeliet Nature medicine 9 (6), 653-660, 2003 | 5828 | 2003 |
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele P Carmeliet, V Ferreira, G Breier, S Pollefeyt, L Kieckens, M Gertsenstein, ... Nature 380 (6573), 435-439, 1996 | 5508 | 1996 |
| Angiogenesis in life, disease and medicine P Carmeliet Nature 438 (7070), 932-936, 2005 | 4500 | 2005 |
| Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, ... Cancer research 59 (22), 5830-5835, 1999 | 3619 | 1999 |
| Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis P Carmeliet, Y Dor, JM Herbert, D Fukumura, K Brusselmans, ... Nature 394 (6692), 485-490, 1998 | 3398 | 1998 |
| Basic and therapeutic aspects of angiogenesis M Potente, H Gerhardt, P Carmeliet Cell 146 (6), 873-887, 2011 | 3051 | 2011 |
| Hypoxia and inflammation HK Eltzschig, P Carmeliet New England Journal of Medicine 364 (7), 656-665, 2011 | 2228 | 2011 |
| Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions P Carmeliet, L Moons, A Luttun, V Vincenti, V Compernolle, M De Mol, ... Nature medicine 7 (5), 575-583, 2001 | 2163 | 2001 |
| VEGF as a key mediator of angiogenesis in cancer P Carmeliet Oncology 69 (Suppl. 3), 4-10, 2005 | 2146 | 2005 |
| Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases P Carmeliet, RK Jain Nature reviews Drug discovery 10 (6), 417-427, 2011 | 1833 | 2011 |
| Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis P Carmeliet, MG Lampugnani, L Moons, F Breviario, V Compernolle, ... Cell 98 (2), 147-157, 1999 | 1602 | 1999 |
| uPAR: a versatile signalling orchestrator F Blasi, P Carmeliet Nature reviews Molecular cell biology 3 (12), 932-943, 2002 | 1564 | 2002 |
| Molecular mechanisms of blood vessel growth EM Conway, D Collen, P Carmeliet Cardiovascular research 49 (3), 507-521, 2001 | 1502 | 2001 |
| Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 A Luttun, M Tjwa, L Moons, Y Wu, A Angelillo-Scherrer, F Liao, JA Nagy, ... Nature medicine 8 (8), 831-840, 2002 | 1442 | 2002 |
| Role of PFKFB3-driven glycolysis in vessel sprouting K De Bock, M Georgiadou, S Schoors, A Kuchnio, BW Wong, ... Cell 154 (3), 651-663, 2013 | 1408 | 2013 |
| Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration B Oosthuyse, L Moons, E Storkebaum, H Beck, D Nuyens, K Brusselmans, ... Nature genetics 28 (2), 131-138, 2001 | 1360 | 2001 |
| Phenotype molding of stromal cells in the lung tumor microenvironment D Lambrechts, E Wauters, B Boeckx, S Aibar, D Nittner, O Burton, ... Nature medicine 24 (8), 1277-1289, 2018 | 1310 | 2018 |
